Abstract

Up to 2% of the population is affected with alopecia areata (AA), a prevalent chronic tissue-specific autoimmune disease that causes hair loss. The specific pathobiology of AA is still unknown, however the most widely accepted idea is that an immunological process led the hair follicle's immune privilege to collapse. The etiology of AA is influenced by numerous environmental and genetic variables. One or more well-defined patches, more diffuse or total hair loss of the scalp (alopecia totalis), or hair loss of the entire body are all clinically treated for AA using a variety of clinical approaches (alopecia universalis). Corticosteroids and other immunomodulators, minoxidil, and contact immunotherapy are some of the available treatments for AA.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.